Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · see citing works

Biochemistry and molecular cell biology of diabetic complications

Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · see citing works

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H. J., Ziyadeh, F. N., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152 · see citing works

Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A. C., Bursell, S., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103 · see citing works

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works

Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB

Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 826 · see citing works

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

Hammes, H., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 523 · see citing works

Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study

Wei, M., Gaskill, S. P., Haffner, S., & Stern, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1167 · Cited by 515 · see citing works

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.

Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P. J., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513 · see citing works

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

Soulis, T., Cooper, M. E., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diabetes.40.10.1328 · Cited by 446 · see citing works

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

Koya, D., Haneda, M., Nakagawa, H., Isshiki, K., Sato, H., Maeda, S., Sugimoto, T., Yasuda, H., Kashiwagi, A., Ways, D. K., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.439 · Cited by 426 · see citing works

Differential Regulation of Glucose Transport and Transporters by Glucose in Vascular Endothelial and Smooth Muscle Cells

Kaiser, N., Sasson, S., Feener, E. P., Boukobza-Vardi, N., Higashi, S., Moller, D. E., Davidheiser, S., Przybylski, R. J., & King, G. L. (1993) · Diabetes · doi:10.2337/diab.42.1.80 · Cited by 358 · see citing works

Properties and functions of the thiamin diphosphate dependent enzyme transketolase

Schenk, G., Duggleby, R. G., & Nixon, P. F. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00095-8 · Cited by 257 · see citing works

Progression of Nephropathy in Spontaneous Diabetic Rats Is Prevented by OPB-9195, a Novel Inhibitor of Advanced Glycation

Nakamura, S., Makita, Z., Ishikawa, S., YASUMURA, K., Fujii, W., Yanagisawa, K., Kawata, T., & Koike, T. (1997) · Diabetes · doi:10.2337/diab.46.5.895 · Cited by 234 · see citing works

Activation of Nuclear Factor-κB in Cultured Endothelial Cells by Increased Glucose Concentration: Prevention by Calphostin C

Pieper, G. M., & Riaz-ul-Haq (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199710000-00019 · Cited by 197 · see citing works

Antioxidant properties of thiamine

Lukienko, P. I., Melnichenko, N. G., Зверинский, И. В., & Zabrodskaya, S. V. (2000) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf02682257 · Cited by 196 · see citing works

Nonenzymatic glycosylation of hemoglobin.

Stevens, V. J., Vlassara, H., Abati, A., et al. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40462-5 · Cited by 174 · see citing works

Suppression of the Accumulation of Triosephosphates and Increased Formation of Methylglyoxal in Human Red Blood Cells during Hyperglycaemia by Thiamine In Vitro

Thornalley, P. J., Jahan, I., & Ng, R. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002889 · Cited by 107 · see citing works

Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions

Selva, M. L., Beltramo, E., Pagnozzi, F., Bena, E., Molinatti, P. A., Molinatti, G. M., & Porta, M. (1996) · Diabetologia · doi:10.1007/s001250050568 · Cited by 106 · see citing works

Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

Stracke, H. H. G., Hammes, H., Werkmann, D., et al. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-17399 · Cited by 105 · see citing works

Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine

Hammes, H., Bartmann, A., Engel, L., et al. (1997) · Diabetologia · doi:10.1007/s001250050726 · Cited by 87 · see citing works

Blood thiamine levels in outpatients with diabetes mellitus.

Saito, N., Kimura, M., KUCHIBA, A., & Itokawa, Y. (1987) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.33.421 · Cited by 78 · see citing works

Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.

Rossetti, L., & Hu, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116919 · Cited by 60 · see citing works

Bioavailability Assessment of the Lipophilic Benfotiamine as Compared to a Water-Soluble Thiamin Derivative

Bitsch, R., Wolf, M., ller, J. O. R. M. O., et al. (1991) · Annals of Nutrition and Metabolism · doi:10.1159/000177659 · Cited by 59 · see citing works

Pharmacokinetics of thiamine derivatives especially of benfotiamine.

Loew, D. (1996) · PubMed · Cited by 51 · see citing works

Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids

Hammes, H. P., Weiss, A., F�hrer, D., Kr�mer, H. J., Papavassilis, C., & Grimminger, F. (1996) · Diabetologia · doi:10.1007/bf00418338 · Cited by 49 · see citing works

CD18/ICAM-1-dependent oxidative NF-kappaB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells.

Kurose, I., Saito, H., Miura, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119251 · Cited by 44 · see citing works

Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells

Ascher, E., Gade, P. V., Hingorani, A., et al. (2001) · Surgery · doi:10.1067/msy.2001.117194 · Cited by 34 · see citing works

Thiamine oxidative transformations catalyzed by copper ions and ascorbic acid.

Степуро, И. И., Piletskaya, T. P., Степуро, В. И., et al. (1997) · PubMed · Cited by 12 · see citing works

Oxidative stress and diabetic complications

Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461 · see citing works

The Pathobiology of Diabetic Complications

Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · see citing works

Mechanisms of Diabetic Complications

Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury

Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · see citing works

Dietary factors and low-grade inflammation in relation to overweight and obesity

Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098 · see citing works

Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond

Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513 · see citing works

An immune origin of type 2 diabetes?

Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394 · see citing works

Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300 · see citing works

Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification

Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206 · see citing works

Intervention against the Maillard reaction in vivo

Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196 · see citing works

Mitochondrial dysfunction and complications associated with diabetes

Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190 · see citing works

Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics

Rabbani, N., Xue, M., & Thornalley, P. J. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9705-z · Cited by 169 · see citing works

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

Szabo, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00086.x · Cited by 165 · see citing works

Resveratrol-Induced AMP-Activated Protein Kinase Activation Is Cell-Type Dependent: Lessons from Basic Research for Clinical Application

Lan, F., Weikel, K., Cacicedo, J., & Ido, Y. (2017) · Nutrients · doi:10.3390/nu9070751 · Cited by 112 · see citing works

Benfotiamine Attenuates Inflammatory Response in LPS Stimulated BV-2 Microglia

Bozic, I., Savic, D., Laketa, D., Bjelobaba, I., Milenkovic, I., Pekovic, S., Nedeljkovic, N., & Lavrnja, I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118372 · Cited by 99 · see citing works

Glyoxalase 1 Modulation in Obesity and Diabetes

Rabbani, N., & Thornalley, P. J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7424 · Cited by 102 · see citing works

Impaired nicotinamide adenine dinucleotide (NAD ⁺ ) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment

Fan, L., Cacicedo, J. M., & Ido, Y. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13303 · Cited by 86 · see citing works

Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse

Ueno, H., Koyama, H., Shoji, T., Monden, M., Fukumoto, S., Tanaka, S., Otsuka, Y., Mima, Y., Morioka, T., Mori, K., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.006 · Cited by 65 · see citing works

Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer’s Disease

Pan, X., Chen, Z., Fei, G., Pan, S., Bao, W., Ren, S., Guan, Y., & Zhong, C. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0067-0 · Cited by 59 · see citing works

Role of ligands of receptor for advanced glycation end products (RAGE) in peripheral artery disease

Yamagishi, S.-I., & Matsui, T. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.2025 · Cited by 31 · see citing works

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy

Oezer, K., Kolibabka, M., Gassenhuber, J., Dietrich, N., Fleming, T., Schlotterer, A., Morcos, M., Wohlfart, P., & Hammes, H.-P. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02135-7 · Cited by 22 · see citing works

Sugar Metabolism in Transketolase Mutants of Escherichia coli

Josephson, B. L., & Fraenkel, D. G. (1974) · Journal of Bacteriology · doi:10.1128/jb.118.3.1082-1089.1974 · Cited by 43 · see citing works

[Peculiarities of reaction activity of the pentose phosphate pathway in different tissues].

Napkhaniuk, V. K., & Савицкий, И. В. (1981) · PubMed

Inhibitory effect of 5-phosphoribosyl 1-pyrophosphate and ADP on the nonoxidative pentose phosphate pathway activity

Hosomi, S., Tara, H., Terada, T., et al. (1989) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(89)90040-6 · Cited by 3 · see citing works

Cardiac and renal pentose phosphate pathway activity in thiamine deficiency.

McCandless, D. W., Curley, A. D., & Cassidy, C. E. (1976) · PubMed

[Metabolic effects related to transketolase inhibition].

Zv, G., Ostrovskiĭ, Y. M., Ss, M., et al. (1980) · PubMed